Recently, chemodynamic therapy (CDT) has represented a new approach for cancer treatment with 14 low toxicity and side effects. Nonetheless, it has been a challenge to improve the therapeutic effect 15 through increasing the amount of reactive oxygen species (ROS). Herein, we increased the amount of 16
Introduction 29
Chemodynamic therapy (CDT) is a tumor therapeutic strategy which generates abundant reactive 30 oxygen species (ROS) in tumor sites via the Fenton reaction or Fenton-like reaction (Tang et al., 2019; 31 Yan et al., 2019). Generally, specific nanomaterials produce ions as catalysts, which cleave the 32 endoperoxide linkages in ROS agents to produce ROS (Bokare and Choi, 2014) . In the classical Fenton 33 reaction, the catalyst is ferrous ions produced under the acidic condition of tumor microenvironment 34 and the ROS agent is the excessive hydrogen peroxide (H2O2) in cancer cells (Li et al., 2015; Chen et 35 al., 2017) . The overproduction of ROS is cytotoxic, which could damage membrane and oxidize lipids 36 in cells, further leading to antitumor performance via apoptosis and/or ferroptosis (Reed and Pellecchia, 37 2012; Yue et al., 2018; Wan et al., 2019; Xu et al., 2019b) . Owing to the fact that CDT needs to be 38 activated by the stimulation of the tumor's endogenous microenvironment, for example, low pH and 39 elevated H2O2 concentration, the overproduction of ROS is almost exclusively achieved at the tumor 40 site and consequently CDT has very low toxicity and side effects on normal tissues (Breunig et al., 41 2008; Chen et al., 2017; Chen et al., 2019) . Compared with other treatment strategies displaying non-42 negligible dark toxicity, like chemotherapy, radiotherapy, photodynamic therapy, and sonodynamic 43 therapy, CDT has the advantage that it is highly selective and specific (Osaki et Since the efficiency of ROS production by Fenton or Fenton-like reaction is dependent on catalysts 48 and ROS agents, a series of studies have enhanced intracellular ROS production mainly in two aspects. 49 On one hand, varieties of materials increasing the amount of ROS are developed from the perspective 50 of catalysts (Zheng et al., 2017; Ma et al., 2019) . Increasing the number of catalyst ions is a 51 straightforward method to promote the efficiency of CDT. Shi group reported the facile synthesis of 52 amorphous iron nanoparticles, which could be rapidly ionized to release Fe 2+ ions in an acidic tumor 53 microenvironment for CDT (Zhang et al., 2016a is higher than normal tissues, the amount of H2O2 is still too low to achieve good therapeutic effect 59 (Szatrowski and Nathan, 1991) . Therefore, from the perspective of ROS agents, it is viable to raise the 60 efficiency of ROS production via increasing the amount of ROS agents in cancer cells (Huo et al., 61 2017) . Ge group constructed integrated multifunctional polymeric nanoparticles in which ascorbyl 62 palmitate molecules can selectively generate H2O2 in tumor tissues, sequentially improving the 63 therapeutic effect of CDT . 64
In addition, it is also a feasible way to load drugs whose treatment principles are based on Fenton or 65
Fenton-like reactions into materials to increase the quantity of ROS agents. Many reports have shown 66 that artemisinin (ART) and its derivatives, as frontline drugs against malarial infections, achieve 67 antimalarial effects by Fenton-like reaction, the specific process of which is that under the catalysis of 68 ferrous heme the weak endoperoxide linkages ( 
Characterization 100
The morphology of nanoparticles was tested by a Tecnai G2 20 TWIN transmission electron 101 microscope (TEM) at an accelerating voltage of 200 kV and a Zeiss Ultra 55 field emission scanning 102 electron microscope (FESEM) equipped with a fieldemission gun operated at 5 kV. Magnetic 103 characterization curves were measured by a Quantum vibrating sample magnetometer (VSM) at 300 104 K. Dynamic light scattering (DLS) data, including the size, zeta potential and light scattering intensity 105 of the nanoparticles were measured at 25 o C on a Zetasizer Nano ZS90 analyzer (Malvern Instrument 106 Ltd). Fourier transform infrared (FT-IR) spectra were obtained via a FT-IR spectrometer (Thermofisher 107
Nicolet 6700). Ultraviolet spectrophotometer (UV-Vis) spectra were recorded at 25 o C on a Perkin-108
Elmer Lambda 750 spectrophotometer. The concentration of metal ions was obtained on a P-4010 109 inductively coupled plasma-atomic emission spectrometry (ICP-AES). Confocal laser scanning 110 microscopy (CLSM) images were acquired using a Nikon C2+ laser scanning confocal microscope. 111
Flow cytometry analysis was operated on a flow cytometer (Beckman Coulter Gallios) at 37 o C. 112
Synthesis of Magnetic Nanoparticles 113
Magnetic nanoparticles (MNP) were prepared via a modified solvothermal reaction (Wang et al., 114 2019a). FeCl3·6H2O (1.8 g), Na3Cit·2H2O (1.2 g) and NaOAc (4.8 g) were dissolved in 88 mL ethylene 115 glycol with sonicated in an ultrasonic bath for 10 minutes, then the mixture was stirred vigorously for 116 30 minutes. The resulting solution was then transferred into a autoclave, which was sealed and heated 117
for 12 h at 200 o C. After cooling down to room temperature, separated by a magnet, the product was 118 washed alternately with ethanol and deionized water for 3 times, then redispersed in water for 119 subsequent use. 120
Preparation and Release Study of Drug-loaded MNP in Vitro 121
Three drugs were loaded into MNP, including ART, DHA, AS, respectively. 6 mg of MNP were added 122 into 2 mL of deionized water and then sonicated for 5 min to form a homogeneous dispersion. Then 123 1.5 mg of ART dissolved in 1 mL of ethanol was added to the dispersion and the dispersion was shaken 124 up for 24 h at room temperature. Subsequently, liquid of the dispersion was removed by rotary 125 evaporation at 40 o C. The product was washed with water for 3 times via a magnet and then collected 126 for further use. After treating with NaOH-containing ethanol solution at 50 °C for 30 minutes, the 127 unloaded ART in the collected supernatant was converted to a UV active compound and detected by a 128 UV-visible spectrometry at an excitation wavelength of 292 nm. According to the following 129 formulation, the drug loading contents (LC) were calculated: LC (%) = (the drug loaded in MNP 130 weight) / (total nanoparticles weight) × 100 %. 131
The methods of loading DHA and AS into MNP were similar to the above method, except the mass 132 ratio of MNP and the drug, and the volume ratio of water and ethanol. When loading DHA into MNP, 133 10 mg of MNP were added into 2 mL of deionized water and then 3 mg of DHA dissolved in 2 mL of 134 ethanol was added to the dispersion. When loading AS into MNP, 10 mg of MNP were added into 4.95 135 mL of deionized water and then 3 mg of AS dissolved in 0.05 mL of ethanol was added to the 136 dispersion. Furthermore, the method of converting drugs to UV active compounds was different 137 between different drugs. In order to be measured at the wavelength of 238 nm, DHA was treated with 138 ethanol solution containing NaOH at 60 °C for 30 min and AS was treated with NaOH solution (0. were cultured in RPMI-1640 containing 10 % (v/v) FBS, 1 % antibiotics (penicillin/streptomycin, 100 154 U/mL) and DOX (0.5 μg/mL). Cells were incubated in an atmosphere of 5 % CO2 at 37 °C. 155
Cytotoxicity Assays 156
The cytotoxicity of nanoparticles was tested on cells using a standard CCK-8 assay (Jiang et al., 2017 was removed and replaced with an equal volume of fresh solution. The cumulative release of iron ions 169 was calculated as the percentage of total iron ions in the same mass MNP and plotted with time. Each 170 measurement was repeated three times. 171
Detection of Cellular Fe 2+ ions Generation 172
To clarify Fe 2+ ions generation via the nanoparticles in cells, CLSM measurement was performed. 173 MCF-7/ADR cells were seeded in confocal dishes at the density of 1 × 10 5 cells/mL, cultured for 24 h, 174
and then MNP, DHA, MNP-DHA dispersions (200 μg/mL) were added into dishes, respectively. 175
Meanwhile, a dish without adding samples was prepared as a control group. After incubated for 6 h, 176
the culture medium was removed and cells were washed with PBS three times. Then FerroOrange (1 177 μM, an intracellular Fe 2+ ions probe, Ex: 543 nm, Em: 580 nm) dispersed in serum-free medium was 178 added to the cells, and cells were incubated for 30 min in a 37 °C incubator equilibrated with 95 % air 179
and 5 % CO2. Finally, the fluorescence images of cells were captured using a C2+ confocal microscope. 180
Detection of ROS Generation in Vitro 181
In order to measure the generation of ROS, DPBF was selected as the ROS trapper, which can be 182 oxidized by ROS resulting in fluorescence quenching (Ding et al., 2018) . Typically, DPBF (10 μM), 183
FeSO4·7H2O (100 μM) and DHA (100 μM) were dissolved in ethanol quickly, and the above mixture 184
was measured by the UV-vis spectrophotometer for 0, 2, 5, 10, 20, 30, 60, 90 and 120 min at the 185 wavelength of 410 nm, respectively. 186
The production of ROS in MCF-7 and MCF-7/ADR cells was detected by CLSM and flow cytometry 187 (Yang et al., 2019) . DCFH-DA, as a ROS probe, was used to assess intracellular ROS generation 188 ability. Cells were seeded in confocal dishes at a density of 1 × 10 5 cells/mL and incubated for 24 h to 189 allow cell attachment. Then cells were incubated with different materials respectively and the plate 190 without adding samples was as a control group. After incubated for 6 h, the culture medium was 191 removed and cells stained with 1 mL of DCFH-DA (10 μM) dissolved in PBS at 37 °C for 30 min. 192
Afterward, PBS containing DCFH-DA was removed and cells were rinsed three times with fresh PBS. 193
The fluorescence images of cells were captured using a C2+ confocal microscope. 194
Besides, using a flow cytometer ROS production was quantitatively measured. Cells were seeded onto 195 a 6-well plate at a density of 1 × 10 5 cells/mL and treated as the similar steps above to be dyed. Then 196 cells were digested and transferred into centrifuge tubes. Cells were separated via centrifugation for 5 197 min at 1000 rpm and redispersed in PBS (0.5 mL). The fluorescence intensity of DCF was tested by 198 the flow cytometry. 199
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Results and Discussion 200
Preparation and Characterization of Drug-loaded MNP 201
The synthesis method of MNP was slightly modified based on the published solvothermal method 202 (Deng et al., 2005) . The detailed morphological and structural features of MNP were examined by 203 TEM, demonstrating the rough surface and the uniform morphology with the particle size of ~180 nm 204 (Figure 1A) . Meanwhile, FESEM images also showed the spherical structure of MNP (Figure 1B) . In 205 addition, the magnetic hysteresis curves showed no evident remanence and coercivity, suggesting 206 superparamagnetic property of MNP (Figure 1C) . The inset photo that MNP were separated via a 207 magnet also revealed MNP had very good magnetism. 208
As shown in Figure 1D (and Table S1), the hydrodynamic diameter (Dh) of MNP was 200 nm with a 209 narrow PDI of 0.013. After loading drugs, including ART, DHA and AS, the average sizes of MNP-210 ART, MNP-DHA and MNP-AS were 212, 204 and 204 nm, and the PDI were 0.065, 0.026 and 0.092, 211
respectively, which implied that the load of drugs didn't affect the stability of nanoparticles. 212
Furthermore, the particle size, as shown by DLS, was larger than that shown by TEM and SEM, which 213
was probably due to the interaction between nanoparticles and surrounding water molecules. 214
The FT-IR spectra demonstrated the successful loading of drugs (Figure 1E and Figure S1) with the similar drug LC, latter experiments could be more comparable. 224
In order to understand the drug release behavior, the drug release profiles of drug-loaded MNP were 225 investigated. As shown in Figure 1F , the cumulative release of ART was about 45.5 % and DHA was 226 about 42.9 % over 24 h, which confirmed that the capacities of MNP to hold ART and DHA in 227 physiological environment were similar. Actually, the solubility of DHA was slightly lower than ART, 228 so during the first 2 hours of the release process, ART exhibited a distinct rapid release behavior, which 229 DHA didn't (Wang et al., 2007; Ansari et al., 2011) . In addition, the cumulative release of AS reached 230 72.1 % over 24 h, indicating that AS was more hydrophilic than ART and DHA, which was consistent 231
with the reported work (Xu et al., 2019a) . 232
In Vitro Biocompatibility and Cytotoxicity Assays 233
The cytotoxicity of nanoparticles to different cells was assessed using CCK-8 assays (Jiang et al., 234 2017) . As shown in Figure S3 , after incubation with blank MNP for 24 h, there was no obvious toxic 235 effect on HEK-293T cells, and cell viability retained above 90 % even with a high concentration up to 236 200 μg/mL, which indicated good biocompatibility of blank MNP. 237
To evaluate the cytotoxicity of ART and its derivatives to cancer cells, MCF-7 cells were incubated 238 with blank MNP, the drugs and the drug-loaded MNP for 24 h, respectively. As shown in Figure 2A 90 %, and 50 %, respectively, which is far greater than the sum of cell viability reduced by the two 248 agents alone. This finding showed that ART and its derivatives had a particularly significant 249 enhancement to MNP of inhibitory effects on cell viability, even exceeding the killing effect of the 250 agent itself. 251
The MNP-DHA, which had the best effect on inhibiting cancer cell viability in three MNP loading 252
ART-based drugs, was selected for subsequent experiments. After calculation, the half inhibitory 253 concentration (IC50) of free DHA was 26.10 μg/mL, which was significantly reduced after loading into 254 MNP, changing to 7.76 μg/mL. It was shown that MNP-DHA had a better effect on killing cancer cells 255 than free DHA, which meant the enhancement effects of materials and drugs is mutual, and further 256 demonstrated that the combined use of DHA and MNP was an excellent strategy for enhancing killing 257 cells effects. 258
According to previous reports, ART and its derivatives were sensitive to drug-resistant tumor cells, so 259
we tried to use MNP-DHA to carry out cytotoxicity experiments on MCF-7/ADR cell lines (Zhong et 260 al., 2016; Hu et al., 2019) . As shown in Figure 2D , only 33 % cell viability was obtained after treatment 261 by MNP-DHA at a concentration of 100 μg/mL. The results showed that MNP-DHA also had a great 262 killing effect to MCF-7/ADR cells. To compare the therapeutic effects on drug-resistant cancer cells 263 between MNP-DHA and DOX, the cytotoxicity of DOX on the MCF-7 and MCF-7/ADR cell lines 264 was evaluated. After treatment of cells with free DOX for 24 h, MCF-7 cell viability decreased rapidly, 265
while the viability of MCF-7/ADR cells showed little change (Figure 2E) . Whereas, whether MCF-7 266 or MCF-7/ADR cells, their survival rate became very low after treatment with MNP-DHA for 24 h. 267
Consistent with published studies, the results showed that DHA wasn't a P-gp substrate, as a 268
consequence The generation of Fe 2+ ions was corroborated using a Fe 2+ ions probe known as Ferrorange, which 282 could react with Fe 2+ ions to produce a bright fluorescent substance. Compared with the control and 283 free DHA groups, the cells treated with MNP and MNP-DHA emitted a much stronger orange 284 fluorescence (Figure 3B) , indicating an enormous amount of Fe 2+ ions generated via MNP. 285
In Vitro CDT Mechanism of MNP-DHA 286
It was well-known that endoperoxide linkages could be cleaved with ferrous ions to generate ROS via 287 a Fenton-like route, which further caused apoptosis or ferroptosis of cells (Efferth et al., 2004; Ooko 288 et al., 2015) . To understand the enhanced mechanism of DHA to CDT, an assessment of the ROS 289 generation ability produced by the reaction of DHA with Fe 2+ ions was investigated first. A classical 290 ROS trapper, DPBF, was used to measure ROS generation. As the generation of ROS increased, the 291 absorbance of DPBF decreased (Ding et al., 2018) . As shown in Figure 4A , at the beginning of the 292 reaction, DPBF solution had a strong absorption at 412 nm. With the reaction time increasing, the 293 absorbance of DPBF gradually decreased, indicating that ROS was produced gradually through the 294 interaction of DHA and Fe 2+ ions over time. 295
Afterwards, we compared the ROS yielding ability of different groups by means of flow cytometry and 296 CLSM, including control, blank MNP, free DHA, and MNP-DHA group. A fluorescent probe DCFH-297
DA was chosen to test intracellular ROS generation, which enable to produce fluorescent 2′,7′-298 dichlorofluorescein (DCF) under the combined actions of cellular esterase and ROS (Yuan et al., 2014) . 299
The quantitative fluorescence analysis was measured by flow cytometry (Figure 4B and 4C) . 300 Incubated with or without MNP, the MCF-7 and MCF-7/ADR cells showed no significant difference 301 in the fluorescence intensity of DCF, due to the fact that the concentration of H2O2 in cells was not 302 enough to produce a large amount of ROS with ferrous ions. After incubation with free DHA, the 303 fluorescence intensity of the cells became a little higher, on account of the reaction of naturally existed 304
Fe 2+ ions with DHA. After treatment with MNP-DHA, a significant enhancement of DCF fluorescence 305 in both MCF-7 and MCF-7/ADR cells was clearly observed, owing to the ROS generation from Fe 2+ 306 ions and DHA brought by DHA-loaded nanoparticles. The experiments suggested that more 307 intracellular ROS were produced after treated by MNP-DHA. 308
The results of fluorescence imaging agreed well with flow cytometry. As shown in Figure 4D , whether 309 the cell line used in the experiments was MCF-7 or MCF-7/ADR, the fluorescence observed in control 310
and MNP group was faintest. The fluorescence slightly increased in free DHA group, indicating that 311 moderately amount of ROS was generated. In the MNP-DHA group, the fluorescence was greatly 312 enhanced, which was the strongest of the four groups. Therefore, the results verified that the effect of 313
DHA from MNP-DHA on enhancing the production efficiency of intracellular ROS was very 314 significant. 315
Cytotoxicity Assays of Other Breast Cancer Cells 316
In consideration of the high cytotoxicity of MNP-DHA, we tried to use this combination to conduct 317 toxicity experiments on other canonical lethal breast cancer cell lines that were triple negative (MDA-318 MB-231) and human epidermal growth factor receptor (HER2) overexpressing (MDA-MB-453) ( the Fenton-like reaction in the tumor microenvironment, thereby producing a large amount of ROS to 334 kill tumor cells. In addition, MNP-DHA could overcome the P-gp mediated tumor MDR and could be 335 used to treat other aggressive breast tumors. Altogether, the proposed nanoparticles may provide an 336 effective solution for improving the efficacy of CDT treatment and have a good prospect in the 337 treatment of aggressive breast cancers. 338
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